share_log

Burcon NutraScience (OTCMKTS:BUROF) Share Price Crosses Above Fifty Day Moving Average of $0.52

Defense World ·  Aug 20, 2022 03:41

Burcon NutraScience Co. (OTCMKTS:BUROF – Get Rating) (TSE:BU) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.52 and traded as high as $0.61. Burcon NutraScience shares last traded at $0.57, with a volume of 60,089 shares changing hands.

Burcon NutraScience Trading Down 1.4 %

The firm has a market cap of $61.68 million, a PE ratio of -151.80 and a beta of 1.15. The business's 50-day simple moving average is $0.52 and its 200 day simple moving average is $0.71.

Burcon NutraScience Company Profile

(Get Rating)

Burcon NutraScience Corporation, together with its subsidiary, develops plant proteins and ingredients for use in the food and beverage industries in Canada. The company's products include CLARISOY, a soy protein for use in sports nutrition beverages, dairy alternative yogurts and cheeses, powdered beverage mixes, coffee creamers, and other foods and nutritional products; and Peazazz, a pea protein for dairy alternative products, such as protein bars and crisps, weight management and meal replacement products, and vegetarian and vegan foods, as well as dry blended and ready-to-drink beverages.

Featured Stories

  • Get a free copy of the StockNews.com research report on Burcon NutraScience (BUROF)
  • 2 EV Suppliers Powering To Gains After Raising Views
  • Applied Materials Results Show A Slowing Semiconductor Market
  • MarketBeat: Week in Review 8/15 – 8/19
  • Apple's Stock Could Be On The Verge Of Another 30% Rally
  • Near-Term Headwinds Present An Opportunity In Ross Stores

Receive News & Ratings for Burcon NutraScience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment